Stay updated on ABP 654 for Psoriasis: Moderate-Severe Clinical Trial

Sign up to get notified when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Minor UI update: Revision v3.4.2 replaces v3.4.1 in the page footer, with no changes to study content, eligibility criteria, or results data — To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-11T01:53:58.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 with no user-facing changes to study details or page content.
    Difference
    0.0%
    Check dated 2026-02-04T01:11:37.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary display and new metadata labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus Revision: v3.4.0. Removed the older labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data', and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T00:14:19.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page shows an updated revision label: v3.3.4 replacing v3.3.3. No changes to the study details or content are evident.
    Difference
    0.0%
    Check dated 2026-01-14T01:50:33.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Locations section updated with many new sites across the US, Canada, and other regions, and some previously listed locations were removed (Revision: v3.3.3).
    Difference
    2%
    Check dated 2025-12-23T10:15:29.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Publication notes were updated to indicate that PubMed publications are automatically filled and may not all pertain to the study. The revision label was updated from v3.2.0 to v3.3.2.
    Difference
    0.4%
    Check dated 2025-11-24T21:33:09.000Z thumbnail image

Stay in the know with updates to ABP 654 for Psoriasis: Moderate-Severe Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.